Similar Papers

Paper Title
Journal
Date
Author
High Skp2 Expression Is an Independent Predictor of Unfavorable Outcome in 333 Patients with Diffuse Large B Cell Lymphoma (DLBCL).
Ritsuko Seki ... Takashi Okamura
Blood | VOL. 110
Ritsuko Seki, et. al.Ritsuko Seki ... Takashi Okamura
16 Nov 2007
IX. Is it only about MYC? How to approach the diagnosis of diffuse large B-cell lymphomas.
Leticia Quintanilla‐Martinez
Hematological oncology | VOL. Suppl 33 1
Leticia Quintanilla‐MartinezLeticia Quintanilla‐Martinez
01 Jun 2015
The Construction of Novel Risk Scores in Diffuse Large B-Cell Lymphoma with Diabetes and the Identification of Glycosylation-Related Prognostic Biomarkers
Wenyue Sun ... Xin Wang
Blood | VOL. 142
Wenyue Sun, et. al.Wenyue Sun ... Xin Wang
28 Nov 2023
BCL-2 Expression at the Time of Diagnosis Affects the Clinical Outcome of Patients with Germinal Center and Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Chemo-Immunotherpy
Sulada Pukiat ... Francisco J Hernandez-Ilizaliturri
Blood | VOL. 116
Sulada Pukiat, et. al.Sulada Pukiat ... Francisco J Hernandez-Ilizaliturri
19 Nov 2010
View more papers

More From: British journal of haematology

Paper Title
Journal
Date
Author
Improvement in cutaneous disease with menin inhibitor monotherapy in KMT2A rearranged AML.
John Chadwick ... Emma Searle
British journal of haematology | VOL. -
John Chadwick, et. al.John Chadwick ... Emma Searle
30 Jan 2025
T-cell-based immunotherapies for human immunodeficiency virus patient with relapsed/refractory multiple myeloma: A success story from our clinic.
S Moraru ... Laure Ricard
British journal of haematology | VOL. -
S Moraru, et. al.S Moraru ... Laure Ricard
29 Jan 2025
First relapse in older adults with multiple myeloma: Creating new pathways in uncharted territory.
Tanya M Wildes
British journal of haematology | VOL. -
Tanya M WildesTanya M Wildes
27 Jan 2025
The ITP diagnostic challenge.
Tomás José González-López
British journal of haematology | VOL. -
Tomás José González-LópezTomás José González-López
27 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.